SEOUL, Oct. 3 (Korea Bizwire) — South Korean pharmaceutical companies have joined the global race to develop vaccines and treatments for the novel coronavirus, and several of them have received approval for clinical trials from the country’s drug safety agency. Among the front-runners is Celltrion Inc.’s antiviral antibody treatment candidate called CT-P59 that is currently [...]
SEOUL, Sept. 28 (Korea Bizwire) – The number of South Korean men taking the human papillomavirus (HPV) vaccine, which can prevent cervical cancer, is increasing. The HPV vaccine for adults should be given three times at a certain interval. On average, it takes about six months to complete the inoculation of the vaccine. Considering that [...]
SEOUL, Aug. 25 (Korea Bizwire) — The novel coronavirus pandemic will not end right away even with the development of a vaccine, and lockdowns will not help root out the virus in the long term, local health experts said Tuesday. The country reported 280 new COVID-19 cases as of midnight Tuesday, with unknown infection routes [...]
GAITHERSBURG, Md., Aug. 10 (Korea Bizwire) — Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced its financial results and operational highlights for the second quarter ended June 30, 2020. “Novavax’ unprecedented development activities for NVX-CoV2373 and progress continued through the second quarter,” said Stanley C. Erck, [...]
SEOUL, July 27 (Korea Bizwire) –The vaccination rates among children for diseases like measles and polio in South Korea is higher than those of developed countries such as the U.S., U.K. and Australia with 97 percent of South Korean kids being vaccinated against these diseases in recent years, according to an analysis of related data, [...]
SEOUL, July 26 (Korea Bizwire) — Microsoft co-founder Bill Gates has sent a letter to President Moon Jae-in to express hope to beef up joint work between South Korea and his foundation in responding to the new coronavirus, the presidential office said Sunday. The chief of the Bill & Melinda Gates Foundation said in the [...]
GAITHERSBURG, Md. and MORRISVILLE, N.C., July 23 (Korea Bizwire) — Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, and FUJIFILM Diosynth Biotechnologies (FDB), a world leading contract development and manufacturing organization (CDMO) for biologics, viral vaccines and gene therapies, announced today an agreement to manufacture bulk drug substance [...]
SEOUL, July 21 (Korea Bizwire) — South Korea’s SK Bioscience inked a deal with global pharmaceutical company AstraZeneca to supply a candidate material for a coronavirus vaccine, the local biotech company said Tuesday. The letter of intent (LOI) reached between the two companies and the Ministry of Health and Welfare calls for close cooperation on [...]
GAITHERSBURG, Md., July 20 (Korea Bizwire) — Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced that Gregory M. Glenn, M.D., President of Research and Development, will present progress of NVX-CoV2373, Novavax’ COVID-19 vaccine candidate, at the 2nd International Society for Vaccines Virtual Congress. Dr. Glenn’s presentation will [...]
SEOUL, June 26 (Korea Bizwire) — South Korea has approved 15 candidates for coronavirus treatment drugs and vaccines for clinical trials as it steps up efforts to combat the coronavirus pandemic, the Ministry of Food and Drug Safety said Friday. The candidate materials include two that may be developed into vaccines and 13 that show [...]